ClinicalTrials.Veeva

Menu

Evaluation of Heart Status in Patients of Beta Thalassemia Using Echocardiogram

N

Nanfang Hospital, Southern Medical University

Status

Enrolling

Conditions

Beta Thalassemia

Treatments

Diagnostic Test: Echocardiogram and Hematological Analysis

Study type

Observational

Funder types

Other

Identifiers

NCT04929574
Heart-Beta thalassemia

Details and patient eligibility

About

Heart failure from myocardial iron deposition is a severe complication for patients with transfusion-dependent beta thalassemia . Increased cardiac iron content impacts the contractility of cardiomyocytes and can also lead to myocarditis, pericarditis, and arrhythmias. The severity of cardiac dysfunction depends on the amount of iron deposited in the myocardium.Echocardiogram is used as noninvasive method to observe heart status. The objective of this study is to evaluate the heart status in patients of Beta Thalassemia from southern China.

Enrollment

1,200 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with beta-thalassemia

Exclusion criteria

  • Iron deficiency anemia

Trial design

1,200 participants in 1 patient group

beta thalassemia patients
Treatment:
Diagnostic Test: Echocardiogram and Hematological Analysis

Trial contacts and locations

1

Loading...

Central trial contact

Xiangmin Xu, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems